Investors all-in on Mag 7 stocks face weighty market decision in 2026

Investors are currently facing a challenging period of high concentration in the S&P 500 Index as we head into 2026. A small number of mega-cap technology and AI-related companies are dominating the index’s performance and risk, prompting investment managers to advise clients to diversify their portfolios.

During an annual portfolio review process, it is crucial for investors to pay extra attention to opportunities to broaden their holdings within the U.S. market, as well as across both value and overseas stocks. Diversification is key to building resiliency in a portfolio, according to Nick Ryder, the chief investment officer at Kathmere Capital Management.

Ryder expressed concerns about investors being too concentrated in the “Magnificent 7” stocks, which currently make up about 35% of the U.S. large-cap stock market index. To combat this concentration risk, he recommended diversifying outside of the mega-cap growth segment and U.S. equity companies.

It’s not just Ryder advising investors to diversify away from the Mag 7. Ed Yardeni, the president of Yardeni Research, suggested investors should be underweight the Mag 7 but overweight the “Impressive 493,” referring to the remaining 493 S&P 500 stocks.

One way investors can stay invested in the U.S. market while reducing concentration risk in top holdings is through equal-weight S&P 500 ETFs. The Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) is one example that has seen significant inflows this year.

While momentum stocks and value stocks have both performed well in 2025, Ryder believes that owning value stocks is crucial for long-term success as stock prices revert to the mean. He recommended considering a value fund like the Vanguard Value ETF (VTV) for diversification within the U.S. large-cap space.

Investors with a domestic bias should also be aware of the significant gains from value stocks overseas this year. Non-U.S. value stocks have seen impressive returns, with the iShares MSCI Intl Value Factor ETF (IVLU) up close to 44% year-to-date.

Despite these gains, Ryder believes that many value stocks remain underpriced, offering significant discounts relative to historical norms. Value stocks are currently cheaper than the market, presenting an attractive opportunity for investors looking to diversify their portfolios.

In conclusion, diversification across different sectors and regions is essential for investors looking to navigate the highly concentrated S&P 500 Index. By considering value stocks both domestically and overseas, investors can build more resilient portfolios and potentially capitalize on undervalued opportunities in the market. The world of technology is constantly evolving, with new innovations and advancements being made every day. One of the most exciting areas of this evolution is in the field of artificial intelligence (AI). AI is the simulation of human intelligence in machines that are programmed to think and learn like humans. This technology has the potential to revolutionize industries and change the way we live and work.

One of the key areas where AI is making a significant impact is in the healthcare industry. AI has the potential to transform the way healthcare is delivered, making it more efficient, accurate, and personalized. From diagnosing diseases to developing treatment plans, AI has the ability to improve patient outcomes and save lives.

One of the most promising applications of AI in healthcare is in medical imaging. AI algorithms are being developed that can analyze medical images such as X-rays, MRIs, and CT scans with a level of accuracy that rivals human radiologists. This can help to speed up the diagnosis process and ensure that patients receive the appropriate treatment in a timely manner.

AI is also being used to develop personalized treatment plans for patients. By analyzing large amounts of data, AI algorithms can identify patterns and trends that can help doctors to tailor treatment plans to individual patients. This can lead to more effective treatments and better outcomes for patients.

Another area where AI is making a big impact in healthcare is in medical research. AI algorithms can analyze large datasets and identify potential drug targets more quickly and accurately than traditional methods. This can help to accelerate the drug discovery process and bring new treatments to market faster.

AI is also being used to improve the efficiency of healthcare systems. By analyzing data on patient outcomes, hospital admissions, and resource utilization, AI algorithms can help to optimize healthcare delivery and reduce costs. This can help to make healthcare more accessible and affordable for everyone.

While the potential benefits of AI in healthcare are vast, there are also challenges that need to be addressed. One of the biggest concerns is around data privacy and security. AI algorithms rely on large amounts of data to make accurate predictions, and there are concerns about how this data is being collected, stored, and used.

There are also concerns about the impact of AI on jobs in the healthcare industry. While AI has the potential to automate certain tasks and improve efficiency, there are worries about the displacement of healthcare workers. It will be important for policymakers to address these concerns and ensure that AI is used in a way that benefits both patients and healthcare workers.

Overall, the potential of AI in healthcare is immense. From improving diagnostics to developing personalized treatment plans, AI has the ability to transform the way healthcare is delivered. By addressing the challenges and harnessing the opportunities, we can ensure that AI improves healthcare outcomes for everyone.